Global pharma industry supplier ACG on Tuesday said it will invest Rs 600 crore to build Asia's largest capsules manufacturing unit near Aurangabad in Maharashtra.
The facility in the backward Marathwada region will create 1,000 jobs directly and indirectly by 2023, as per a statement.
It will produce 40 billion capsules annually and will also have a research and development centre adjoining it, it said, adding that pharma and nutraceutical companies domestically and abroad will form the clients.
Officials from ACG signed a memorandum of understanding (MoU) with the Government of Maharashtra for Rs 600 crore investment in the backward Marathwada region of the state, as per the statement. The state government has accorded it the status of a 'mega project'.
Our vision to be a future-ready solutions provider to the pharma industry anywhere in the world and our proposed investment of approximately USD 100 million (over Rs 600 crore) in this state-of-the-art plant, is an integral part of ACG's mission to double our capsule manufacturing capacity to 240 billion capsules a year," ACG Managing Director Karan Singh said.
SpaceX capsule with world's first all-civilian orbital crew returns safely
Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule
Maharashtra SSC result 2021 out on mahresult.nic.in; result site crashes
U'khand Forest Dept conserves 73 rare, threatened, endangered plant species
Pune chemical plant fire: Search operation resume; firm owner summoned
Reliance credit quality not impacted by Aramco decision: Moody's
Top headlines: Voda Idea too raises tariffs; NoBroker becomes an unicorn
NoBroker.com becomes unicorn; raises $210 mn at $1 bn valuation
TVS Motor to invest Rs 1,200 cr in Future Tech, EV; signs MoU with TN govt
Ola elevates Balachandar N as Group Chief People Officer
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)